It was a privilege to present Norman Stockbridge with the 2024 HFC Lifetime Achievement Award for contributions to regulatory science, advocacy for the community without walls,and his disciplined integrity that has improved many pts. via CV and renal therapies.⁦Robert Harrington⁩

Congrats to Dr. Norman Stockbridge on receiving the Lifetime Achievement Award🏆

Dr. Stockbridge has made impressive contributions to the CV research & regulatory arena making a significant impact on the way clinical trials are conducted.
No one is more deserving of this award!

Starting now! HFC Spring Think Tank and Working Group Reports!

Stay tuned to hear about HFCs great work this past year

@HFCollaboratory Spring Think Tank 2024! Always a great opportunity to learn from the best in the business! And so great to see the next class of HFC interns thriving!! #heartfailure #thinktank Christopher O'Connor Mona Fiuzat

Still time to Register to attend the April 27 2024 Inova Advanced Heart Failure and Shock Symposium virtually. Deadline April 25.
Hear updates on the latest research and best practices from our guest faculty and our outstanding Inova experts
advancedhfsymposium.com

Thanks Nature Medicine for the invitation to discuss equity in clinical trials.

nature.com/articles/s4159…
⚫️ acknowledge our past
⚫️ strategize for the future: representation according to disease prevalence/severity, negotiation, scholarship, funding, community partnership

📣4 days until the HFSA Webinar: Preparing for your First Job

🔴How to find a job and when to apply
🔴Staying local or need to move
🔴Academics, community, or private practice
🔴Start/join a HF specialty program
& more!

🗓️April 14 8-9PM ET
🔗hfsa.org/event/hfsa-men…

now calling on all at #ishlt2024 -let’s support pts w advanced ❤️ and 🫁 sarcoidosis & #saysarcoidosis
Emer Joyce Farooq Sheikh Jennifer Cowger Paul Scheel Ahmet Kilic The ISHLT Mitchell Psotka ChonyAlbert MD Ryan J Tedford MD Anu Lala-Trindade Journal of Cardiac Failure Michelle Sharp saysarcoidosis Jonathan Chrispin

And we got a moderated session of ❤️ transplant in breast cancer. Thank you Inova Schar Heart and Vascular Jamie Kennedy Shashank Sinha, MD, MSc, FACC, FAHA Ana Barac, MD, PhD, FACC, FAHA InovaCVfellows
#thefutureisbright

#SimPub in JACC Journals
Does HF trial enrollment contribute to underutilization of therapies among diverse groups in clinical practice?

HFC Intern ISABELLA CAVAGNA presents on Clinical Trial Inclusion manuscript out now at the link below🔗
sciencedirect.com/science/articl…

Thanks for the HF Collaboratory Mona Fiuzat Christopher O'Connor Mitchell Psotka for the chance to discuss NLP endpoint adjudication in clinical trials!

Great potential to make trials more efficient, faster, and more reproducible

Why are Black patients more likely to die waiting for a #HeartTransplant ?

What happens AFTER a patient gets listed for a 💗?

👇🏾 our paper in JAMA

jamanetwork.com/journals/jama/…

So excited for this next phase of improving care for #cardiogenicshock survivors, with our first post shock clinic today!! Iyad Isseh إياد نبيل العسّة Vanessa Blumer, MD, FACC Mitchell Psotka Shashank Sinha, MD, MSc, FACC, FAHA Behnam N. Tehrani, MD Alex Truesdell Inova Schar Heart and Vascular

Congratulations Lucrecia M. Burgos, MD!
This is incredibly well-deserved - you are a shining star & the best is yet to come ⭐️❤️‍🔥

We are looking forward to hosting you Inova Schar Heart and Vascular & being part of this incredible project AHA Science

Christopher O'Connor Shashank Sinha, MD, MSc, FACC, FAHA Mitchell Psotka Paola Morejón Barragán

🎥Recording HFC podcast #CardioPod Heart of the Matter. Episode 12: The Role of AI in the Future of Clinical Trials and Therapeutic Development

Stay tuned to listen on Apple, Spotify, and YouTube!

NEW HFSA Endorsed Meeting: Inova Schar Heart and Vascular 2024 Advanced Heart Failure and Shock Symposium
Date: April 27, 2024
Location: The Ritz Carlton Pentagon City
CE Credits: 6.25
Learn more >> hfsa.org/event/inova-sc…
#InovaAHF2024

Contemporary approach to cardiogenic shock care: a state-of-the-art review Frontiers in Cardiovascular Medicine

frontiersin.org/articles/10.33…

Eiran Gorodeski, MD, MPH Mitchell Psotka BiykemBozkurt Esp when recognizing intra observer variation in assessing LVEF is 6-14%, enough to jump two categories!

I've always been bothered by arbitrary cutoffs LVEF by which we make decisions for GDMT. Shown here is 'Current HF Classification and the New Proposed Conceptualization of LVEF.' #JACCHF jacc.org/doi/10.1016/j.…

Iyad Isseh إياد نبيل العسّة with an excellent reminder of the unmet need of post-discharge care for #ECMO and #CS survivors at the Inova Schar Heart and Vascular ECMO symposium! Vanessa Blumer, MD, FACC Shashank Sinha, MD, MSc, FACC, FAHA Edward Howard